Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR Will the Injectable Cement Market Achieve During 2025–2034, and What Does It Indicate?

The market for injectable cement has enjoyed robust growth in recent years. It is projected to escalate from $1.45 billion in 2024 to $1.55 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. This growth during the historic period is linked to a rise in osteoporosis cases, an increase in bone fractures, the escalating demand for joint replacement procedures, regulatory greenlights, and the introduction of novel products into the market.

In the coming few years, the market size for injectable cement is predicted to experience robust growth. The market is set to expand to $2 billion by 2029, with a compound annual growth rate (CAGR) of 6.5%. The increase is driven by factors such as the aging population, a surge in concerns related to bone health, healthcare infrastructure development, a rise in outpatient care adoption, and an growing number of sports-related injuries. We can anticipate several trends during this forecast period, including improved biocompatibility, innovations in antibiotic-loaded cement, the application of minimally invasive techniques, personalized patient solutions, and smart cement with tracking features.

What Major Innovations Are Driving the Accelerated Growth of the Injectable Cement Market?

The growth of the injectable cement market is anticipated to be driven by a rise in sports-related injuries. These injuries, which often necessitate medical care and rehabilitation, are typically the result of athletic activities and can include fractures, strains, sprains, and concussions. The surge in these types of injuries can be linked to a rise in athletic participation, more rigorous workout programs, and advancements in athletic accessories that push the body beyond its limits, thus resulting in an increased injury risk among athletes globally. To manage sports-related injuries, injectable cement is used as it provides a trusted, minimally invasive solution for bone enhancement, helps steady fractures, and encourages bone repair which in turn improves surgical outcomes. To illustrate, the National Safety Council, a US based nonprofit that focuses on health and safety, stated that there was a 20% surge in reported sports and leisure injuries in 2021, with a 12% increase in 2022 and a minor 2% rise in 2023. As such, the increment in sports-related injuries is expected to spur the growth of the injectable cement market.

Get Your Free Sample of the Global Injectable Cement Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=19528&type=smp

Who Are the Key Firms Paving the Way for Growth in the Injectable Cement Market?

Major companies operating in the injectable cement market are Johnson & Johnson, 3M Company, Medtronic Plc., Stryker Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew, Arthrex Inc., Cook Medical LLC, Enovis Corporation, Globus Medical Inc., Wright Medical Group N.V, Medacta International, Orthofix Medical Inc., Alphatec Spine Inc. (ATEC Spine), Exactech Inc., Spine Wave Inc., Tecres SpA, Somatex Medical Technologies, Heraeus Medical GmbH, DJO Global Inc., TEKNIMED, G-21, Kyeron Medical Innovations, Graftys SA

What Are the Most Influential Trends Currently Shaping the Injectable Cement Market?

Key players in the injectable cement industry are striving for technological innovation, specifically antibiotic-loaded bone cement, in an effort to improve infection control, enhance patient prognosis, and provide more precise treatment during orthopedic surgeries. Antibiotic-loaded bone cement is a specialized cement variant which includes antibiotics to prevent or treat surgical site infections, particularly in orthopedic operations. For example, in April 2024, Heraeus Medical GmbH, a medical technology company based in Germany, introduced its latest antibiotic-loaded bone cement product, COPAL G+C. This is the first product from the company to receive certification under the MDR. COPAL G+C, containing both gentamicin and clindamycin, provides a targeted infection control for arthroplasty and treats up to 90% of pathogens typically found in prosthetic joint infections.

Get Instant Access to the Global Injectable Cement Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/injectable-cement-global-market-report

What Are the Main Segments of the Injectable Cement Market, and How Are They Evolving?

The injectable cementmarket covered in this report is segmented –

1) By Type: High Viscosity Cement, Low Viscosity Cement, Medium Viscosity Cement

2) By Application: Periprosthetic Fractures, Pelvic Fractures, Other Applications

3) By End User: Hospital, Clinics, Other End Users

Subsegments:

1) By High Viscosity Cement: Calcium Phosphate Cements, PMMA (Polymethyl Methacrylate) Cements

2) By Low Viscosity Cement: Acrylic-Based Injectable Cements, Bioactive Glass Cements

3) By Medium Viscosity Cement: Hybrid Injectable Cements, Composite Injectable Cements

Which Regions Are Essential for the Growth of the Injectable Cement Market?

North America was the largest region in the injectable cement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable cement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Elements Shape the Definition of the Injectable Cement Market?

Injectable cement is a type of bone cement used in various orthopedic procedures to stabilize fractures, support implants, or fill bone defects. It is designed to be injected into a targeted body area, often under imaging guidance, allowing for precise placement and minimal invasiveness. Injectable cements are valued for providing immediate stabilization, facilitating minimally invasive procedures, and improving patient outcomes in orthopedic care.

Browse Through More Similar Reports By The Business Research Company:

Chemical Injection Skids Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chemical-injection-skids-global-market-report

Contrast Media Injectors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/contrast-media-injectors-global-market-report

Injection Molded Plastics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/injection-molded-plastics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: